Year |
Citation |
Score |
2019 |
Raju A, Pimple P, Stafkey-Mailey D, Farrelly E, Shetty S. Abstract 168: A Real-World Claims Analysis of Costs Among Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease Receiving Empagliflozin or Other Antihyperglycemic Agents Circulation: Cardiovascular Quality and Outcomes. 12. DOI: 10.1161/HCQ.12.SUPPL_1.168 |
0.308 |
|
2017 |
Lokhandwala T, Bhor M, Stafkey-Mailey D, Chen H, Elliott BM. Comparison of treatment characteristics between patients diagnosed with immune thrombocytopenia (ITP) and treated with thrombopoietin receptor agonists (TPO-RA). Journal of Clinical Oncology. 35: e18314-e18314. DOI: 10.1200/JCO.2017.35.15_SUPPL.E18314 |
0.359 |
|
2014 |
Rouleau A, Guiraud-Diawara A, Landsman-Blumberg P, Lokhandwala T, Stafkey-Mailey D, Verpillat P. Assessing Balance in Baseline Characteristics Using Different Propensity Adjusted Methods for Bipolar I Mixed Disorder Patients Initiating Asenapine Versus Other Oral Atypical Antipsychotics. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: A577. PMID 27201940 DOI: 10.1016/j.jval.2014.08.1946 |
0.345 |
|
2014 |
Mytelka DS, Li L, Stafkey-Mailey D, Liepa AM, Hess LM, Farrelly E, Eaddy M. Treatment patterns and outcomes among patients with high-intermediate/high-risk diffuse large B-cell lymphoma in the USA. Hematology (Amsterdam, Netherlands). PMID 25551431 DOI: 10.1179/1607845414Y.0000000228 |
0.308 |
|
2011 |
Rascati KL, Richards KM, Ott CA, Goddard AW, Stafkey-Mailey D, Alvir J, Sanders KN, Mychaskiw M. Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder. Psychiatric Services (Washington, D.C.). 62: 1032-40. PMID 21885581 DOI: 10.1176/PS.62.9.PSS6209_1032 |
0.334 |
|
2009 |
Marshall TS, McCombs JS, Stafkey-Mailey D. Impact of patient selection criteria and treatment history on comparisons of alternative therapies: a case study of atypical antipsychotics. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 12: 473-80. PMID 18798808 DOI: 10.1111/J.1524-4733.2008.00458.X |
0.483 |
|
2008 |
Zolfaghari S, McCombs J, Stafkey-Mailey D, Ganapathy V, Kim E, Pikalov A. PMH75 IMPACT OF ALTERNATIVE TREATMENTS ON POST-TREATMENT COSTS FOR PATIENTS WITH SCHIZOPHRENIA Value in Health. 11: A132. DOI: 10.1016/S1098-3015(10)70421-6 |
0.536 |
|
2008 |
Ganapathy V, McCombs J, Stafkey-Mailey D, Kim E, Pikalov A. PMH74 IMPACT OF ALTERNATIVE TREATMENTS ON POST TREATMENT COSTS FOR PATIENTS WITH BIPOLAR DISORDER Value in Health. 11: A132. DOI: 10.1016/S1098-3015(10)70420-4 |
0.488 |
|
2008 |
Ganapathy V, McCombs J, Stafkey-Mailey D, Kim E, Pikalov A. PMH53 IMPACT OF ALTERNATIVE TREATMENTS ON DURATION OF DRUGTHERAPY BY PATIENTS WITH BIPOLAR DISORDER Value in Health. 11: A125. DOI: 10.1016/S1098-3015(10)70400-9 |
0.501 |
|
2008 |
Stafkey-Mailey D, McCombs J, Hay J. A comparison of treatment-emergent diabetes among atypical and typical antipsychotic users European Psychiatry. 23: S148-S149. DOI: 10.1016/j.eurpsy.2008.01.898 |
0.415 |
|
2008 |
McCombs JS, Stafkey-Mailey D, Marshall T. Sensitivity of comparisons of TTAD across antipsychotics to patient selection criteria and model specification in a retrospective paid claims analysis European Psychiatry. 23. DOI: 10.1016/J.Eurpsy.2008.01.840 |
0.373 |
|
2005 |
Sud A, Kline-Rogers EM, Eagle KA, Fang J, Armstrong DF, Rangarajan K, Otten RF, Stafkey-Mailey DR, Taylor SD, Erickson SR. Adherence to medications by patients after acute coronary syndromes. The Annals of Pharmacotherapy. 39: 1792-7. PMID 16204391 DOI: 10.1345/Aph.1G249 |
0.317 |
|
Show low-probability matches. |